There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...

Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing ...

specifically pulmonary hypertension secondary to left heart failure with preserved ejection fraction (“PH-HFpEF”). In patients with PH-HFpEF, chronic heart failure leads to increased blood pressure in ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

Although finerenone has kidney protective effects in patients with chronic kidney disease and type 2 diabetes, it does not appear to slow kidney function decline in patients with heart failure with ...

Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Serum uric acid (SUA), a product of ...

007). With chronic kidney disease present in approximately 50% of patients with heart failure with mildly reduced or preserved ejection fraction — and associated with higher morbidity and ...

The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2024 October 23–27.

A shocking new report has revealed that a TUI jet with 200 passengers experienced a "catastrophic failure" upon its descent in the UK before skidding off the runway. The Air Accidents ...

Therapies are needed for patients with heart failure with mildly reduced or preserved ejection fraction. New research findings on the nonsteroidal mineralocorticoid receptor antagonist finerenone ...

NICE's guideline on diagnosis and management of chronic heart failure in adults recommends that reviews are offered every 6 months for people whose condition is stable, but clinical experts ...